Price (delayed)
$15.3
Market cap
$1.03B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.98
Enterprise value
$918.59M
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The CellFX® System is the first
There are no recent dividends present for PLSE.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.